Health Canada
www.hc-sc.gc.ca
Common menu bar links
Drugs and Health Products
Past Consultations
- Consultation on VICH revised guideline 18: Quality-Impurities: Residual solvents in New Veterinary Medicinal Products, Active Substances and Excipients (step 4)
- Consultation on VICH guideline 46: Studies to evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-producing Animals: Metabolism Study to determine the Quantity and Identify the Nature of Residues (step 4).
- Consultation on VICH guideline 47: Studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: Comparative metabolism studies in laboratory animals (step 4)
- Consultation on VICH guideline 48: Studies to evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-producing Animals: Marker Residue Depletion Studies to establish Product Withdrawal Periods (step 4)
- Consultation on VICH guideline 49: Guidelines for the Validation of Analytical Methods used in Residue Depletion Studies (step 4)
- Food and Drug Regulations - Project Number 1621 - Schedule F Amendment
- Consultations - Veterinary Drugs Directorate's (VDD's) Animal Tissue Form
- Proposed Regulatory Amendment to Prohibit the Importation of Unapproved Drugs Destined for Use in Food-producing Animals - Responses Prepared by Health Canada to the Stakeholder Consultation
- Appendix A - Benefits of the Regulatory Amendment as Described in Response to Health Canada's Consultation Letter Dated November 2, 2004
- Appendix B - List of Stakeholders Who Participated in this Consultation
- Consultation on Health Canada's Revised Document on Antimicrobial Categorization
- Draft Guidance for Industry on Management of Regulatory Submissions
